Incidence of diabetes according to metabolically healthy or unhealthy normal weight or overweight/obesity in postmenopausal women: the Women's Health Initiative
Authors:
- 24 February 2020
- journal article
- research article
- Published by Wolters Kluwer Health in Menopause
- Vol. 27 (6) , 640-647
Abstract
Objective: To determine the relationship of metabolic weight categories with incident diabetes mellitus (DM) in postmenopausal women. Methods: The Women's Health Initiative (WHI) enrolled 161,808 postmenopausal women aged 50 to 79 years. We included those with cardiovascular disease (CVD) biomarkers and free of CVD and prevalent DM (n = 17,043) at baseline. Normal weight was defined as a body mass index (BMI) ≥18.5 and 2, and waist circumference (WC) 2 or WC ≥88 cm. Metabolically healthy was based on P < 0.0001), MHO (n = 624 cases) (HR 1.68, 95% CI 1.40-2.00, P < 0.0001), and MUHO (n = 1,365 cases) (HR 4.51, 95% CI 3.82-5.35, P < 0.0001). Conclusions: Among postmenopausal women, MUHNW and MHO confer an approximate doubling in the risk and MUHO more than a four-fold increased risk for developing DM.Keywords
This publication has 33 references indexed in Scilit:
- Metabolically obese status with normal weight is associated with both the prevalence and severity of angiographic coronary artery diseaseMetabolism, 2013
- The effect of the menopausal transition on body composition and cardiometabolic risk factorsMenopause, 2012
- "Predictability of body mass index for diabetes: Affected by the presence of metabolic syndrome?"BMC Public Health, 2011
- Impact of BMI and the Metabolic Syndrome on the Risk of Diabetes in Middle-Aged MenDiabetes Care, 2010
- Impact of Body Mass Index and the Metabolic Syndrome on the Risk of Cardiovascular Disease and Death in Middle-Aged MenCirculation, 2010
- Harmonizing the Metabolic SyndromeCirculation, 2009
- Are Metabolically Normal but Obese Individuals at Lower Risk for All-Cause Mortality?Diabetes Care, 2009
- Longitudinal changes in abdominal fat distribution with menopauseMetabolism, 2009
- Baseline associations between postmenopausal hormone therapy and inflammatory, haemostatic, and lipid biomarkers of coronary heart diseaseThrombosis and Haemostasis, 2005
- Design of the Women’s Health Initiative Clinical Trial and Observational StudyControlled Clinical Trials, 1998